Bifidobacterium longum infantis M-63 and Improved Gut Microbiota Composition

• Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review.

  • 2025-12
  • Review
  • Health science reports 8(12)
  • • Mojtaba Memariani
    • Hamed Memariani

  • PubMed: 41341415
  • DOI: 10.1002/hsr2.71564

  3 Insights on

  • Improved Gut Microbiota Composition

  • Low evidence

  Exploring therapeutic options such as antibiotics, probiotics, dietary interventions, fecal microbiota transplantation, phage therapy, and helminth therapy may present valuable opportunities for gut microbiota modification in MS treatment.

  Effect

  Beneficial

  Effect size

  Small